Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Carcinoma, Neuroendocrine 1Adenocarcinoma, Follicular 1

Interventions

Thyroidectomy 5Iodine-131 5Surgical Procedures, Operative 3selpercatinib 2lenvatinib 2anlotinib 2Ultrasonography 2Transurethral Resection of Prostate 2Sorafenib 2Molecular Diagnostic Techniques 2Interviews as Topic 2Focus Groups 2Biopsy, Fine-Needle 2trastuzumab deruxtecan 1trametinib 1pralsetinib 1pembrolizumab 1gallium Ga 68 dotatate 1dabrafenib 1Triiodothyronine 1Thyroxine 1Thyrotropin Alfa 1Surveys and Questionnaires 1Routinely Collected Health Data 1Radiotherapy, Adjuvant 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Minimally Invasive Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Thyroid Neoplasms × gallium Ga 68 dotatate × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡